Some previous studies presented an association of RAD51 variant allele 135C with an elevated breast cancer risk only in BRCA2 mutation carrier, but not in BRCA1 mutation carriers or non-carriers or unselected populations [15], [25], [26], [42]. This evidence concerns the gene BRCA2 and breast carcinoma.